QuidelOrtho (QDEL) CHRO logs RSU vesting and tax share withholding

Rhea-AI Filing Summary

QuidelOrtho Corporation’s Chief Human Resources Officer, Ronald Lee Bowman, reported the vesting of 2,938 restricted stock units on January 29, 2026, which converted into the same number of common shares at $0 per share. Following this, 1,210 shares were surrendered at $27.41 per share to cover tax withholding obligations.

After these transactions, Bowman directly owned 3,375 shares of QuidelOrtho common stock. He also continued to hold 5,878 restricted stock units, which are scheduled to vest in equal installments on January 29, 2027 and January 29, 2028, each unit representing one share of common stock.

Insider Trade Summary

2,938 shares exercised/converted

Mixed 3 txns

Insider Bowman Ronald Lee

Role Chief Human Resources Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	2,938	$0.00	--
Grant/Award	Common Stock	2,938	$0.00	--
Tax Withholding	Common Stock	1,210	$27.41	$33K

Holdings After Transaction: Restricted Stock Units — 5,878 shares (Direct); Common Stock — 4,585 shares (Direct)

Footnotes (1)

1. Reflects release of restricted stock units that were previously reported on a Form 4. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. 2,938 shares vested on January 29, 2026; the remaining 5,878 shares will vest in equal installments on January 29, 2027 and January 29, 2028

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bowman Ronald Lee

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/29/2026		A		2,938(1)	A	$0	4,585	D
Common Stock	01/29/2026		F		1,210(2)	D	$27.41	3,375	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	01/29/2026		M			2,938	(4)	(4)	Common Stock	2,938	$0	5,878	D

Explanation of Responses:

1. Reflects release of restricted stock units that were previously reported on a Form 4.

2. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

3. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

4. 2,938 shares vested on January 29, 2026; the remaining 5,878 shares will vest in equal installments on January 29, 2027 and January 29, 2028

Remarks:

	/s/ Jennifer Ahn, attorney-in-fact for Ronald Lee Bowman	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did QuidelOrtho (QDEL) report for Ronald Lee Bowman?

QuidelOrtho reported that Chief Human Resources Officer Ronald Lee Bowman had 2,938 restricted stock units vest into common shares. On the same date, some of those shares were withheld to satisfy tax obligations related to the vesting.

How many QuidelOrtho (QDEL) RSUs vested for the CHRO on January 29, 2026?

On January 29, 2026, 2,938 restricted stock units vested for QuidelOrtho’s Chief Human Resources Officer. Each unit converted into one share of common stock, reflecting previously granted equity awards now becoming directly owned shares.

Why were 1,210 QuidelOrtho (QDEL) shares disposed of in this Form 4?

The 1,210 shares were disposed of to satisfy tax withholding obligations from the RSU vesting. The issuer withheld these common shares at a price of $27.41 per share, rather than the executive selling shares in an open-market transaction.

How many QuidelOrtho (QDEL) shares does Ronald Lee Bowman own after the reported transactions?

After the reported RSU vesting and tax withholding, Ronald Lee Bowman directly owns 3,375 shares of QuidelOrtho common stock. This reflects his updated beneficial ownership position following the January 29, 2026 equity events.

What QuidelOrtho (QDEL) restricted stock units remain unvested for the CHRO?

After 2,938 units vested, 5,878 restricted stock units remain unvested for the Chief Human Resources Officer. These RSUs are scheduled to vest in equal installments on January 29, 2027 and January 29, 2028, each unit equal to one common share.

What do QuidelOrtho (QDEL) restricted stock units represent in this Form 4?

Each restricted stock unit in this Form 4 represents the right to receive one share of QuidelOrtho common stock. When units vest, they convert into actual shares, which may trigger tax obligations typically settled in cash or by share withholding.